SOAT inhibition can block the E<sub>1</sub>S-stimulated proliferation of T47D breast cancer cells, demonstrating that SOAT is an interesting novel drug target from the group of E<sub>1</sub>S uptake carriers for anti-proliferative breast cancer therapy.
SOAT inhibition can block the E<sub>1</sub>S-stimulated proliferation of T47D breast cancer cells, demonstrating that SOAT is an interesting novel drug target from the group of E<sub>1</sub>S uptake carriers for anti-proliferative breast cancer therapy.
SOAT inhibition can block the E<sub>1</sub>S-stimulated proliferation of T47D breast cancer cells, demonstrating that SOAT is an interesting novel drug target from the group of E<sub>1</sub>S uptake carriers for anti-proliferative breast cancer therapy.
SOAT inhibition can block the E<sub>1</sub>S-stimulated proliferation of T47D breast cancer cells, demonstrating that SOAT is an interesting novel drug target from the group of E<sub>1</sub>S uptake carriers for anti-proliferative breast cancer therapy.
Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6).
Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6).
Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6).